Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The investigators wish to determine the time to disease progression for benign neurofibromas
treated with Levulan Kerastick topical photosensitizer and red light photodynamic therapy
(PDT) in patients with neurofibromatosis type 1 (NF1).
The investigators also wish to measure tumor size for control and treatment tumors in order
to gain insights into tumor growth rates.